The effects of novel macrocyclic chelates on the targeting properties of the <sup>68</sup>Ga-labeled Gastrin releasing peptide receptor antagonist RM2.

Authors:
Wang Y; Yuan H; Tang S; Liu Y; Cai P and 3 more

Journal:
EJNMMI Res

Publication Year: 2023

DOI:
10.1186/s13550-023-01005-1

PMCID:
PMC10247930

PMID:
37285007

Journal Information

Full Title: EJNMMI Res

Abbreviation: EJNMMI Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Ethics approval and consent to participateThe Ethics Committee for Southwest Medical University (2022-03-22) approved the animal study. All methods were carried out following relevant guidelines and regulations, and all methods are reported per ARRIVE guidelines (https://arriveguidelines.org). Consent for publicationWritten informed consent was obtained from all individual participants included in the study. Competing interestsThe authors declare no conflict of interest. Competing interests The authors declare no conflict of interest."

Evidence found in paper:

"Funding The National Natural Science Foundation of China for funding this work (U20A20384); the Sichuan Science and Technology Foundation (2021YJ0131)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025